Phase II Randomized Study of Physiologic Testosterone Replacement in Premenopausal, HIV-Positive Women
NCT00004400
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Los Angeles, California, United States
View Trial DetailsNCT Number: NCT00004781
OBJECTIVES: I. Evaluate the development of oral manifestations of human immunodeficiency virus infection in relationship to the onset of immunologic alterations and systemic symptoms in different risk groups: gay/bisexual men, male intravenous drug users, and female intravenous drug users.
II. Evaluate the immune and inflammatory response to periodontal and other microbial pathogens.
III. Evaluate the bacterial species infecting the oral cavity in patients in these risk groups.
Looking for future studies?
Notify Me0 year and older
All sexes
Observational
PROTOCOL OUTLINE:
Patients undergo a periodontal assessment every 6 months until medically unable to continue. The oral/dental exam includes saliva and gingival crevicular fluid analysis and, as indicated, oral photographs.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
PROTOCOL ENTRY CRITERIA:
--Disease Characteristics-- Human immunodeficiency virus infection (HIV) seropositive or seronegative At risk for HIV, i.e.: Gay/bisexual men Male intravenous drug users Female intravenous drug users No acquired immunodeficiency syndrome Currently enrolled in Columbia Presbyterian Medical Center protocol "The Natural History and Progression of HIV Infection"
National Institute of Dental and Craniofacial Research (NIDCR)
Nih
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00004400
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Los Angeles, California, United States
View Trial DetailsNCT00004276
Acquired Immunodeficiency Syndrome, Actinomycetales Infections
View Trial DetailsNCT00002399
AIDS-Related Opportunistic Infections, Bacterial Infections and Mycoses
Tucson, Arizona, United States
View Trial DetailsNCT00004664
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
View Trial Details